Event details
October 15, 2026
Deloitte San Diego Office – One Paseo
12830 El Camino Real, San Diego, CA 92130
Details and registration

Event summary

Join Cooley and Deloitte for an interactive panel discussion covering key considerations and strategies for navigating the initial public offering (IPO) process. This year, there will also be a focus on comparing IPOs to other going-public transactions, such as reverse mergers and deSPACs.

Featured panelists

  • Ed Lake, Chief Administrative Officer, AEVEX Aerospace
  • Arvind Kush, former Chief Financial Officer, Candid Therapeutics and RayzeBio
  • Carlos Ramirez, Partner, Cooley
  • Neha Krishnamohan, Chief Financial Officer and Chief Business Officer, Latigo Biotherapeutics
  • Tasia Blazevich, National Life Science Capital Markets Leader, Deloitte
  • Cayce Denton, Chief Financial Officer, Setara Bioscience

For more information, please email Aimee Nguyen.

Details and registration

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.